Data Linkage: Spanning The Clinical To Commercial Gap

The landscape of clinical trials is experiencing a transformative shift as sponsors increasingly integrate their trials with diverse and complementary datasets, marking a rapid and evolving trend across the industry. The potential applications of linked datasets are limitless, promising benefits across both clinical and commercial spectrums. This includes, but is not limited to, quantifying healthcare resource utilization, supporting future drug repurposing and label expansion, augmenting long-term follow-up, and enriching the understanding of the longitudinal patient journey.

The key resource lies in connecting Clinical Trial Data (CTD) with Real-World Data (RWD) at the patient level, resulting in a comprehensive view of the patient journey spanning before, during, and after the trial.

Download the presentation below to explore these topics in greater detail and develop a scalable data linkage strategy that enhances both clinical development and commercial launch plans.